WELLGISTICS HEALTH O.N.

Wellgistics Health released figures for the quarter ended 30/06/2026: loss per share $7.13 (prior year: -$5,500). Revenue fell to $1.8 million, down 77.15% from $7.8 million in the year-ago quarter. » More on finanzen.net

Wellgistics Health has appointed Brett Thompson as advisory chief technology officer; his predecessor Srini Kalla is stepping down. Thompson brings more than 30 years of enterprise and health-technology experience, including pharmacy management system integrations, EHR standards (FHIR, HL7) and compliance (HIPAA, SOC 2, ISO/IEC 27001). The appointment comes as the company pursues a direct-to-consumer strategy and planned licensing expansions with DataMeds AI and DataVault AI, while the company faces financial pressure (market capitalization $7.35 million, stock 93% below its 52-week high). » More on de.investing.com

Executive Chairman Suren Ajjarapu and President & Interim Co-CEO Prashant Patel exercised warrants and together acquired 200,000 common shares at $10.00 each. The shares resulting from the exercise are subject to existing lock-up agreements; there are now 2,847,198 common shares outstanding in total, of which shareholders holding about 1,533,930 shares have agreed to a 90-day hold. The stock is trading at $2.93, near its 52-week low, and the market capitalization is about $7.65 million. The company operates in health IT with the AI platform EinsteinRx and has proposed a name change to DataMeds AI. » More on de.investing.com